Intra-Cellular Therapies Inc. ( ITCI) - Stock Earnings
Stock symbol ITCI is outdated, potentially delisted? Maybe it is available on other exchange?
ITCI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q2 | -16.2 million USD | 161.4 million USD |
| 2024Q3 | -26.3 million USD | 175.2 million USD |
| 2024Q4 | -16.9 million USD | 199.2 million USD |
ITCI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -256.3 million USD | 249.1 million USD |
| 2023 | -139.7 million USD | 464.4 million USD |
| 2024 | -74.7 million USD | 680.9 million USD |
ITCI
Price: $131.87
52 week price:
Earnings Per Share: -0.73 USD
P/E Ratio: -180.64
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 307914
Ebitda: -22.8 millionMarket Capitalization: 14.0 billion